Efficacy and Safety of Mirabegron in Men with Overactive Bladder Symptoms and Benign Prostatic Hyperplasia.

Mullen, Gregory R; Kaplan, Steven A

Mullen, Gregory R; Kaplan, Steven A.

Affiliation

Mullen GR; Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY, 10029, USA.
Kaplan SA; Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY, 10029, USA. steven.kaplan@mountsinai.org.

Curr Urol Rep ; 22(1): 5, 2021 Jan 07.

Article in En | MEDLINE | ID: mdl-33411109

Subject(s)

Acetanilides/therapeutic use; Adrenergic beta-3 Receptor Agonists/therapeutic use; Lower Urinary Tract Symptoms/drug therapy; Prostatic Hyperplasia/drug therapy; Thiazoles/therapeutic use; Urinary Bladder, Overactive/drug therapy; Urological Agents/therapeutic use; Aged; Humans; Lower Urinary Tract Symptoms/etiology; Male; Prostatic Hyperplasia/complications; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Bladder, Overactive/complications

Key words

Lower urinary tract symptoms; Mirabegron; Overactive; Prostatic hyperplasia; Urinary bladder

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / Thiazoles / Urinary Bladder, Overactive / Adrenergic beta-3 Receptor Agonists / Lower Urinary Tract Symptoms / Urological Agents / Acetanilides Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Systematic_reviews Limits: Aged / Humans / Male Language: En Journal: Curr Urol Rep Journal subject: UROLOGIA Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google